|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-14
|
|
pubmed:abstractText |
In this report the authors describe the use of the hemostatic agent recombinant activated factor VII (rFVIIa) in the perioperative treatment of hemorrhages in the central nervous system that are associated with warfarin therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-3085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
737-40
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12691397-Acute Disease,
pubmed-meshheading:12691397-Aged,
pubmed-meshheading:12691397-Anticoagulants,
pubmed-meshheading:12691397-Craniotomy,
pubmed-meshheading:12691397-Factor VII,
pubmed-meshheading:12691397-Factor VIIa,
pubmed-meshheading:12691397-Female,
pubmed-meshheading:12691397-Heart Valve Prosthesis,
pubmed-meshheading:12691397-Hematoma, Subdural,
pubmed-meshheading:12691397-Hematoma, Subdural, Acute,
pubmed-meshheading:12691397-Hemostasis, Surgical,
pubmed-meshheading:12691397-Humans,
pubmed-meshheading:12691397-Male,
pubmed-meshheading:12691397-Middle Aged,
pubmed-meshheading:12691397-Preoperative Care,
pubmed-meshheading:12691397-Recombinant Proteins,
pubmed-meshheading:12691397-Treatment Outcome,
pubmed-meshheading:12691397-Warfarin
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings.
|
|
pubmed:affiliation |
Department of Neurological Surgery and Pediatrics, University of Illinois College of Medicine at Peoria, Illinois 61656, USA.
|
|
pubmed:publicationType |
Journal Article
|
